摘要
目的探讨中晚期肝癌的治疗方法和预后因素.方法将我院323例住院的中晚期肝癌患者,经股动脉穿刺行肝动脉灌注化疗栓塞术(Transcatheterarterialchemoembolization,TACE)的病例资料进行回顾性分析,依据影像学,血生化指标及生存时间判断疗效.结果323例患者术后肿块缩小占60.3%,症状改善,1年生存率48.9%,2年生存率6.2%,3年生存率4.9%,中位生存期14.9个月.结论介入治疗是中晚期肝癌的有效治疗手段,可减轻症状,延长患者寿命,但要注意并发症的发生.
ObjectiveTo study the therapeutic means and prognostic anlysis of advanced hepatocellular carcinoma. Methods323 patients with advanced hepatocellular carcinama ,who received transcatheter arterial chemoembolization (TACE),clinical data got through follow-up were analyzed retrospectively on. Imagiology ,biochemical index and the survival time were observed. ResultsThe overall effective rate of the TACE patients was 60.3%, the survival rates of 1,2 and 3 years were 48.9%,6.2% and 4.9%,mediam survival times was 14.9 months. ConclusionsInterventioned therapy is a effective therapeutic means for advanced hepatocellular carcinoma ,and improve quality of life and survival time. But we must pay attention to complications rates.
出处
《现代临床医学生物工程学杂志》
2005年第2期110-112,共3页
Journal of Modern Clinical Medical Bioengineering
关键词
中晚期肝癌
介入治疗
疗效
预后
Hepatocellular neoplasms
Interventioned therapy
Curative effect
Prognosis
